IDYA

IDEAYA Biosciences, Inc.

What the Jungle Thinks

1

Bullish

0

Neutral

0

Bearish

Based on 1 article from 1 persona

Coverage by Portfolio Manager

Gene Poole 1 article

IDEAYA's Eye Cancer Drug Just Got the Biggest Stage in Oncology. The Scoreboard Looks Real.

4/22/2026